EXHIBIT 11
NANOPIERCE TECHNOLOGIES, INC.
COMPUTATION OF NET LOSS PER SHARE
<TABLE>
<CAPTION>
Three months ended September 30,
2000 1999
---- ----
<S> <C> <C>
Net loss $( 689,559) ( 261,361)
========== ==========
Weighted average number of common
shares outstanding 35,816,632 30,380,483
Common equivalent shares representing
shares issuable upon exercise of
outstanding options and warrants - -
---------- ----------
35,816,632 30,380,483
========== ==========
Basic and diluted loss per share
applicable to common shareholders $( .02) ( .01)
========== ==========
Stock options and warrants are not considered in the calculations as the impact of
the potential common shares (16,324,500 shares at September 30, 2000 and 5,345,000
shares at September 30, 1999) would be to decrease net loss per share.
</TABLE>
<PAGE>